Ji P - Search Results

1

Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis.

Gong Y, Zhang J, Ji P, Ling H, Hu X, Shao ZM. Gong Y, et al. Among authors: ji p. Cancer Med. 2018 Aug;7(8):4156-4169. doi: 10.1002/cam4.1668. Epub 2018 Jul 9. Cancer Med. 2018. PMID: 29984914 Free PMC article.

2

Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study.

Gong Y, Liu YR, Ji P, Hu X, Shao ZM. Gong Y, et al. Among authors: ji p. Sci Rep. 2017 Mar 27;7:45411. doi: 10.1038/srep45411. Sci Rep. 2017. PMID: 28345619 Free PMC article.

3

Development and Validation of Nomograms for Predicting Overall and Breast Cancer-Specific Survival in Young Women with Breast Cancer: A Population-Based Study.

Gong Y, Ji P, Sun W, Jiang YZ, Hu X, Shao ZM. Gong Y, et al. Among authors: ji p. Transl Oncol. 2018 Dec;11(6):1334-1342. doi: 10.1016/j.tranon.2018.08.008. Epub 2018 Sep 4. Transl Oncol. 2018. PMID: 30189361 Free PMC article.

4

Modified lymph node ratio improves the prognostic predictive ability for breast cancer patients compared with other lymph node staging systems.

Jin ML, Gong Y, Pei YC, Ji P, Hu X, Shao ZM. Jin ML, et al. Among authors: ji p. Breast. 2020 Feb;49:93-100. doi: 10.1016/j.breast.2019.11.003. Epub 2019 Nov 14. Breast. 2020. PMID: 31783315 Free PMC article.

5

Association between socioeconomic factors at diagnosis and survival in breast cancer: A population-based study.

Ji P, Gong Y, Jiang CC, Hu X, Di GH, Shao ZM. Ji P, et al. Cancer Med. 2020 Mar;9(5):1922-1936. doi: 10.1002/cam4.2842. Epub 2020 Jan 20. Cancer Med. 2020. PMID: 31960597 Free PMC article.

6

Value of CXCL8-CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study.

Wang RX, Ji P, Gong Y, Shao ZM, Chen S. Wang RX, et al. Among authors: ji p. Breast Cancer Res Treat. 2020 Jun;181(3):561-570. doi: 10.1007/s10549-020-05660-z. Epub 2020 May 2. Breast Cancer Res Treat. 2020. PMID: 32361849

7

The Burden and Trends of Breast Cancer From 1990 to 2017 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2017.

Ji P, Gong Y, Jin ML, Hu X, Di GH, Shao ZM. Ji P, et al. Front Oncol. 2020 May 12;10:650. doi: 10.3389/fonc.2020.00650. eCollection 2020. Front Oncol. 2020. PMID: 32528870 Free PMC article.

8

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets.

Gong Y, Ji P, Yang YS, Xie S, Yu TJ, Xiao Y, Jin ML, Ma D, Guo LW, Pei YC, Chai WJ, Li DQ, Bai F, Bertucci F, Hu X, Jiang YZ, Shao ZM. Gong Y, et al. Among authors: ji p. Cell Metab. 2021 Jan 5;33(1):51-64.e9. doi: 10.1016/j.cmet.2020.10.012. Epub 2020 Nov 11. Cell Metab. 2021. PMID: 33181091 Free article.

9

Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy.

Wu HL, Gong Y, Ji P, Xie YF, Jiang YZ, Liu GY. Wu HL, et al. Among authors: ji p. J Hematol Oncol. 2022 Apr 27;15(1):45. doi: 10.1186/s13045-022-01263-x. J Hematol Oncol. 2022. PMID: 35477416 Free PMC article. Review.

10

In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer.

Ji P, Gong Y, Jin ML, Wu HL, Guo LW, Pei YC, Chai WJ, Jiang YZ, Liu Y, Ma XY, Di GH, Hu X, Shao ZM. Ji P, et al. Sci Adv. 2022 Jul;8(26):eabl8247. doi: 10.1126/sciadv.abl8247. Epub 2022 Jun 29. Sci Adv. 2022. PMID: 35767614 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,778 results

Search Page

Filters